246 related articles for article (PubMed ID: 26289776)
1. Humanized microbiota mice as a model of recurrent Clostridium difficile disease.
Collins J; Auchtung JM; Schaefer L; Eaton KA; Britton RA
Microbiome; 2015 Aug; 3():35. PubMed ID: 26289776
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.
Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL
World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611
[TBL] [Abstract][Full Text] [Related]
3. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
Tomkovich S; Stough JMA; Bishop L; Schloss PD
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
[TBL] [Abstract][Full Text] [Related]
4. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
6. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Lv Z; Peng G; Liu W; Xu H; Su J
Antimicrob Agents Chemother; 2015 Jul; 59(7):3726-35. PubMed ID: 25824219
[TBL] [Abstract][Full Text] [Related]
7. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
Lesniak NA; Schubert AM; Sinani H; Schloss PD
mSphere; 2021 May; 6(3):. PubMed ID: 33952668
[TBL] [Abstract][Full Text] [Related]
8. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
[TBL] [Abstract][Full Text] [Related]
9. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
[TBL] [Abstract][Full Text] [Related]
10. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
Song Y; Garg S; Girotra M; Maddox C; von Rosenvinge EC; Dutta A; Dutta S; Fricke WF
PLoS One; 2013; 8(11):e81330. PubMed ID: 24303043
[TBL] [Abstract][Full Text] [Related]
11. Mouse relapse model of Clostridium difficile infection.
Sun X; Wang H; Zhang Y; Chen K; Davis B; Feng H
Infect Immun; 2011 Jul; 79(7):2856-64. PubMed ID: 21576341
[TBL] [Abstract][Full Text] [Related]
12. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.
Weingarden AR; Chen C; Bobr A; Yao D; Lu Y; Nelson VM; Sadowsky MJ; Khoruts A
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G310-9. PubMed ID: 24284963
[TBL] [Abstract][Full Text] [Related]
13. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.
Buffie CG; Jarchum I; Equinda M; Lipuma L; Gobourne A; Viale A; Ubeda C; Xavier J; Pamer EG
Infect Immun; 2012 Jan; 80(1):62-73. PubMed ID: 22006564
[TBL] [Abstract][Full Text] [Related]
14. A review of the economics of treating Clostridium difficile infection.
Mergenhagen KA; Wojciechowski AL; Paladino JA
Pharmacoeconomics; 2014 Jul; 32(7):639-50. PubMed ID: 24807468
[TBL] [Abstract][Full Text] [Related]
15. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.
Reeves AE; Theriot CM; Bergin IL; Huffnagle GB; Schloss PD; Young VB
Gut Microbes; 2011; 2(3):145-58. PubMed ID: 21804357
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
17. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
Hota SS; Sales V; Tomlinson G; Salpeter MJ; McGeer A; Coburn B; Guttman DS; Low DE; Poutanen SM
Clin Infect Dis; 2017 Feb; 64(3):265-271. PubMed ID: 28011612
[TBL] [Abstract][Full Text] [Related]
18. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.
Britton RA; Young VB
Gastroenterology; 2014 May; 146(6):1547-53. PubMed ID: 24503131
[TBL] [Abstract][Full Text] [Related]
19. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
